Thu. 14 Mar 2024, 8:22am ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.10) by 20 percent. The company reported quarterly sales of $4.555 million which missed the analyst consensus estimate of $6.068 million by 24.93 percent. This is a 18.71 percent increase over sales of $3.837 million the same period last year.